Neurostimulation therapy for non-neurogenic overactive bladder in children : a meta-analysis
dc.contributor.author | Fernández Bonilla, José Nicolas | |
dc.contributor.author | Chua, Michael E. | |
dc.contributor.author | Ming, Jessica M. | |
dc.contributor.author | Silangcruz, Jan Michael | |
dc.contributor.author | Zu'bi, Fadi | |
dc.contributor.author | Dos Santos, Joana | |
dc.contributor.author | Lorenzo, Armando J. | |
dc.contributor.author | Braga, Luis H. | |
dc.contributor.author | Iglesias Lopes, Roberto | |
dc.contributor.corporatename | Pontificia Universidad Javeriana. Facultad de Medicina. Departamento de Cirugía y Especialidades. Grupo de Investigación de Cirugía y Especialidades | |
dc.date.accessioned | 2020-06-02T22:01:21Z | |
dc.date.available | 2020-06-02T22:01:21Z | |
dc.date.created | 2017 | |
dc.description.abstractenglish | Objective: To assess the efficacy and safety of neurostimulation for non-neurogenic overactive bladder in children, we conducted a meta-analysis of randomized controlled trials (RCTs). Materials and methods: A systematic literature search was performed on August 2016. RCTs were evaluated according to the Cochrane Collaboration risk of bias assessment. Number of patients with post-treatment partial response (PR) (50%-89%), complete response (CR) (≥90%), and full response (FR) (100%) were extracted for relative risk (RR) and 95% confidence interval (CI). Effect estimates were pooled using the Mantel-Haenszel method with random effect model if significant inter-study heterogeneity (P <.1) was noted. Subgroup analysis was performed according to each treatment setting (PROSPERO CRD42016043502). Results: Five eligible studies (245 patients) were included. Overall effect estimates showed that compared with standard urotherapy, neurostimulation demonstrated significantly better ≥50% (PR + CR + FR) response (RR = 2.8, 95% CI 1.1-7.2), but not ≥90% (CR + FR) response (RR = 8.28, 95% CI 0.65-105.92). Clinic-based neurostimulation had significantly better treatment outcomes for both ≥50% (PR + CR + FR) and ≥90% (CR + FR) responses (RR = 3.24, 95% CI 1.89-5.57; RR = 20.81, 95% CI 2.97-145.59, respectively), whereas a self-administered regimen showed no differences for both ≥50% (PR + CR + FR) and ≥90% (CR + FR) response rates between treatment groups (RR = 2.61, 95% CI 0.48-14.15; RR = 3.55, 95% CI 0.19-67.82, respectively). No serious adverse events were reported. Conclusion: Neurostimulation therapy may lead to better partial improvement of non-neurogenic overactive bladder; however, it may not render a definitive complete response. Office-based neurostimulation seems more efficacious than self-administered neurostimulation. Further RCTs are needed to compare outcomes of the 2 regimens. | spa |
dc.description.paginas | 201-207 | spa |
dc.description.quartilescopus | Q1 | spa |
dc.description.quartilewos | Q3 | spa |
dc.format | spa | |
dc.format.mimetype | application/pdf | spa |
dc.format.soporte | Papel / Electrónico | spa |
dc.identifier | https://www.sciencedirect.com/science/article/pii/S0090429517307987?via%3Dihub | spa |
dc.identifier.doi | https://doi.org/10.1016/j.urology.2017.08.003 | spa |
dc.identifier.issn | 0090-4295 / 1527-9995 (Electrónico) | spa |
dc.identifier.uri | http://hdl.handle.net/10554/49579 | |
dc.language | spa | spa |
dc.rights.licence | Atribución-NoComercial 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
dc.source | Urology; Vol. 110 (2017) | spa |
dc.title | Neurostimulation therapy for non-neurogenic overactive bladder in children : a meta-analysis | spa |
dc.type | info:eu-repo/semantics/article | |
dc.type.hasversion | http://purl.org/coar/version/c_ab4af688f83e57aa | |
dc.type.local | Artículo de revista | spa |
Archivos
Bloque original
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- 1-s2.0-S0090429517307987-main.pdf
- Tamaño:
- 940.9 KB
- Formato:
- Adobe Portable Document Format
- Descripción:
- Artículo
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 2.54 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: